SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001601830-22-000023
Filing Date
2022-05-10
Accepted
2022-05-10 16:34:01
Documents
51
Period of Report
2022-05-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rxrx-20220510.htm   iXBRL 8-K 32106
2 EX-99.1 exhibit991-q0122.htm EX-99.1 86799
3 EX-99.2 rxrx2022q1websitefinal.htm EX-99.2 34388
7 GRAPHIC a20220505pipelineq1update-.jpg GRAPHIC 73674
8 GRAPHIC rxrx2022q1websitefinal001.jpg GRAPHIC 63234
9 GRAPHIC rxrx2022q1websitefinal002.jpg GRAPHIC 97717
10 GRAPHIC rxrx2022q1websitefinal003.jpg GRAPHIC 107991
11 GRAPHIC rxrx2022q1websitefinal004.jpg GRAPHIC 94163
12 GRAPHIC rxrx2022q1websitefinal005.jpg GRAPHIC 217101
13 GRAPHIC rxrx2022q1websitefinal006.jpg GRAPHIC 89431
14 GRAPHIC rxrx2022q1websitefinal007.jpg GRAPHIC 83450
15 GRAPHIC rxrx2022q1websitefinal008.jpg GRAPHIC 105330
16 GRAPHIC rxrx2022q1websitefinal009.jpg GRAPHIC 119194
17 GRAPHIC rxrx2022q1websitefinal010.jpg GRAPHIC 119113
18 GRAPHIC rxrx2022q1websitefinal011.jpg GRAPHIC 179729
19 GRAPHIC rxrx2022q1websitefinal012.jpg GRAPHIC 133212
20 GRAPHIC rxrx2022q1websitefinal013.jpg GRAPHIC 111892
21 GRAPHIC rxrx2022q1websitefinal014.jpg GRAPHIC 121560
22 GRAPHIC rxrx2022q1websitefinal015.jpg GRAPHIC 141643
23 GRAPHIC rxrx2022q1websitefinal016.jpg GRAPHIC 127328
24 GRAPHIC rxrx2022q1websitefinal017.jpg GRAPHIC 72072
25 GRAPHIC rxrx2022q1websitefinal018.jpg GRAPHIC 94034
26 GRAPHIC rxrx2022q1websitefinal019.jpg GRAPHIC 117442
27 GRAPHIC rxrx2022q1websitefinal020.jpg GRAPHIC 111880
28 GRAPHIC rxrx2022q1websitefinal021.jpg GRAPHIC 115246
29 GRAPHIC rxrx2022q1websitefinal022.jpg GRAPHIC 120037
30 GRAPHIC rxrx2022q1websitefinal023.jpg GRAPHIC 110613
31 GRAPHIC rxrx2022q1websitefinal024.jpg GRAPHIC 108239
32 GRAPHIC rxrx2022q1websitefinal025.jpg GRAPHIC 125207
33 GRAPHIC rxrx2022q1websitefinal026.jpg GRAPHIC 133926
34 GRAPHIC rxrx2022q1websitefinal027.jpg GRAPHIC 113982
35 GRAPHIC rxrx2022q1websitefinal028.jpg GRAPHIC 132193
36 GRAPHIC rxrx2022q1websitefinal029.jpg GRAPHIC 127455
37 GRAPHIC rxrx2022q1websitefinal030.jpg GRAPHIC 73255
38 GRAPHIC rxrx2022q1websitefinal031.jpg GRAPHIC 114295
39 GRAPHIC rxrx2022q1websitefinal032.jpg GRAPHIC 121135
40 GRAPHIC rxrx2022q1websitefinal033.jpg GRAPHIC 130045
41 GRAPHIC rxrx2022q1websitefinal034.jpg GRAPHIC 111506
42 GRAPHIC rxrx2022q1websitefinal035.jpg GRAPHIC 85065
43 GRAPHIC rxrx2022q1websitefinal036.jpg GRAPHIC 99140
  Complete submission text file 0001601830-22-000023.txt   6110740

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rxrx-20220510.xsd EX-101.SCH 1905
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rxrx-20220510_lab.xml EX-101.LAB 24831
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rxrx-20220510_pre.xml EX-101.PRE 13045
45 EXTRACTED XBRL INSTANCE DOCUMENT rxrx-20220510_htm.xml XML 11122
Mailing Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101
Business Address 41S RIO GRANDE STREET SALT LAKE CITY UT 84101 (385) 269-0203
RECURSION PHARMACEUTICALS, INC. (Filer) CIK: 0001601830 (see all company filings)

IRS No.: 464099738 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40323 | Film No.: 22910286
SIC: 2836 Biological Products, (No Diagnostic Substances)